deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04293380

Amniotic Fluid Ischemia Modified Albumin as a Novel e Prenatal Diagnostic Marker for Down Syndrome

Sponsor: Karadeniz Technical University

Conditions Cytokines Down Syndrome Prenatal Stress
Interventions amniosyntesis
Updated 5 times since 2020 Last updated: Dec 15, 2020 Started: Mar 1, 2012 Primary completion: Jun 1, 2016 Completion: Sep 1, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04293380, this NA trial focuses on Cytokines and Down Syndrome and remains completed. Sponsored by Karadeniz Technical University, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotRecruiting~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

    Status: Recruiting → Completed

  5. Apr 2020 — Jan 2021 [monthly]

    Recruiting NA

    First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Karadeniz Technical University
Data source: Karadeniz Technical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations